Drug Discovery World

AUGUST 9, 2023

Darren Mercer, Chief Executive of CSP, said: “We are thrilled to acquire AxeroVision, and in particular the pipeline product AXR-270 which contains a novel selective glucocorticoid receptor agonist formulated in a cutting-edge drug delivery system that overcomes the issues of poor compliance and inefficient delivery of conventional eye drops.”

Drugs 52

Drugs Drug Delivery Systems Drug Delivery Life Science 52

pharmaphorum

OCTOBER 20, 2015

s Chris Evans and HealthPrize Technologies' Katrina Firlik to learn about how their organizations are collaborating to provide an end-to-end connected health solution that tracks, educates, motivates and engages patients to increase adherence and medical literacy and rewards them for compliance with their prescribed regimen.

Drug Delivery 40

Drug Delivery Compliance Drugs 40

Pharmaceutical Technology

JUNE 23, 2022

This challenging environment, in addition to the measures taken to restrict people’s movement in order to reduce the viruses spread, led to many of the vital clinical trials being carried out to shift towards decentralised trial procedures that utilised virtual medicine and direct-to-patient (DtP) drug delivery.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

Drug Discovery World

JULY 31, 2023

Darren Mercer, Chief Executive of CSP, said: “We are thrilled to acquire AxeroVision, and in particular the pipeline product AXR-270 which contains a novel selective glucocorticoid receptor agonist formulated in a cutting-edge drug delivery system that overcomes the issues of poor compliance and inefficient delivery of conventional eye drops. “On

Drug Delivery Systems 52

Drug Delivery Systems Containment Drug Delivery Compliance 52

pharmaphorum

MARCH 14, 2022

This morning, Sandoz announced it has acquired medical and drug delivery device specialist Coalesce Product Development, bolstering its capabilities for the development of respiratory medicines and ‘complex’ generics.

Sales 98

Sales Drug Delivery Marketing Production 98

Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

Roots Analysis

FEBRUARY 22, 2022

Further, in order to improve the quality of life in these patients, companies have developed novel devices capable of delivering a variety of formulations of different drugs / therapies, in an efficient and relatively simple manner. Autoinjector As Emerging Drug Delivery Device.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. Drug-Induced Thrombocytopenia, Gian Paolo Visentin, Chao Yan Liu).

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

OCTOBER 14, 2020

15, 2020 /PRNewswire/ — Seattle Gummy Company’s breakthrough gummy drug program, which delivers Active Pharmaceutical Ingredients (APIs) in its innovative gummy matrix, recently won its first Investigational New Drug Application (IND) approval from FDA on the company’s allergy gummy medication, designated as IND 140312.

Drugs 52

Drugs Allergies Cardiology Drug Delivery 52

XTalks

SEPTEMBER 23, 2020

And in turn, these feelings and experiences of anxiousness can affect medication compliance and adherence. This highlights the importance of optimal drug delivery, including the injection experience itself.

Insulin 98

Insulin Marketing Drug Delivery Compliance 98

The Pharma Data

OCTOBER 27, 2020

3a will continue to advance its industrial design, product usability, labelling compliance, regulatory approval, and production planning work in parallel to its validation studies. .” Final validation studies are planned to be carried out for both RNA test systems in Germany in Q4 2020. About XPhyto Therapeutics Corp.

RNA 52

RNA Drug Delivery Production In-Vitro 52

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

Roots Analysis

MARCH 9, 2022

Given the evident benefits of biologics over small molecule drugs (including high efficacy, target specificity and favorable safety profiles), the biopharmaceutical market is poised to witness continued and consistent growth over the next several years. Biopharmaceutical Excipient Manufacturing Market. Our Social Media Platform. Web: [link].

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

XTalks

JULY 5, 2022

A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Novartis trains and guides associates with a structured program consisting of ethics, risk and compliance.

Life Science 52

Life Science Compliance Packaging Packaging 52

pharmaphorum

JUNE 22, 2021

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares to give a much-anticipated update to shareholders tomorrow. So far, all the other antibodies are also delivered by intravenous infusion.

Antibody 52

Antibody Protein Drug Delivery FDA Approval 52

The Pharma Data

DECEMBER 17, 2020

Opioid dependence is a serious, chronic, relapsing disease associated with a disproportionate amount of drug-related harm that includes infectious diseases and other health problems, mortality, unemployment, homelessness and social exclusion 6. For more information Fredrik Tiberg , President & CEO Tel. +46 About Camurus.

Clinical Trials 52

Clinical Trials Clinical Trials Drug Delivery Production 52

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. BetterLife Pharma Inc. No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release.

Containment 52

Containment Drug Delivery Compliance Marketing 52

Delveinsight

NOVEMBER 26, 2020

Retinal vein occlusion drug market. The treatment options such as Intravitreal injection of anti-vascular endothelial growth factor (VEGF) drugs, and Intravitreal injection of corticosteroid drugs. Intraocular injections of steroids are another potential treatment for eyes that don’t respond to anti-VEGF drugs.

FDA Approval 63

FDA Approval Marketing Drug Delivery Systems Drugs 63

The Pharma Data

DECEMBER 14, 2020

While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. BetterLife Pharma Inc.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

JANUARY 18, 2021

According to Health Canada, “the information currently available at the Controlled Substances Directorate, 2-bromo-LSD is NOT CONTROLLED under the Schedules to the Controlled Drugs and Substances Act.”. BetterLife Pharma Inc.

Containment 40

Containment Regulation Production Drug Delivery 40

The Pharma Data

JANUARY 16, 2021

It has become the de facto standard equipment for high titer transient protein expression platforms used by many leading Chinese antibody drug pharmaceutical companies and IVD (In Vitro Diagnostics) companies since its launch in Oct. for non-viral cell immunotherapeutic drug development. About JS Bio.

Protein 52

Protein Production Antibody In-Vitro 52

The Pharma Data

NOVEMBER 4, 2020

His broad leadership experience in the pharmaceutical industry, from intellectual property and regulatory compliance to product manufacturing and distribution, presents an exciting opportunity for XPhyto,” said Hugh Rogers, CEO of XPhyto. Thoresen is an important addition to XPhyto’s board of directors. XPhyto Therapeutics Corp.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40

XTalks

FEBRUARY 24, 2021

For many daily insulin users, the experience is an important one, as it is directly related to quality of life and medication compliance. The injection experience is an often-overlooked aspect in insulin administration. We spend a lot of time trying to understand the human elements associated with it.

Insulin 64

Insulin Production Drug Delivery Marketing 64

Drug Discovery World

APRIL 3, 2023

When used as precision chemotherapies, the small size of these delivery vehicles compared to standard antibody technologies offers the potential for increased tissue penetration for hard-to-reach sites such as the centre of solid tumours. For gene therapies, the current challenge faced by developers is targeted delivery.

Antibody 52

Antibody Gene Therapy Gene In-Vitro 52

Drug Discovery World

FEBRUARY 5, 2024

DDW’s Megan Thomas spoke to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. Greg Rossi, Senior Vice President, Head of Oncology, AstraZeneca Europe & Canada “Advances in science and technology have brought us to an incredible inflection point in cancer management and healthcare delivery.

Research 116

Research Gene Sequencing Drug Delivery Systems Trials 116

The Pharma Data

JANUARY 3, 2021

The Company’s pipeline leverages its proprietary bioerodible Durasert® technology for extended intraocular drug delivery including EYP-1901, a potential six-month sustained delivery intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration.

Production 52

Production Sales Development Licensing 52

XTalks

NOVEMBER 30, 2023

For instance, drug delivery devices may meet all technical requirements regarding dosage and delivery methods but fail in practical use by patients. These failures usually result from a development process focusing only on technical aspects and healthcare provider perspectives, neglecting patient input.

Life Science 22

Life Science Production Development Drug Delivery 22

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These medical devices are designed to administer drug subcutaneously. These devices have capability to hold and deliver precise dosages of drugs ranging from a few milliliters to several milliliters.

Drug Delivery 40

Drug Delivery Marketing Insulin Manufacturing 40

Roots Analysis

JANUARY 17, 2024

They offer several advantages over traditional drug delivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination.

Drug Delivery 40

Drug Delivery Contamination Drugs Production 40

pharmaphorum

JUNE 10, 2021

Simply put, the revenues and profits from today’s mainstream drugs fund the scientific discovery that make tomorrow’s breakthrough drugs and critical vaccines possible. The truth about rising drug prices is more nuanced and merits exploration. The Big Misconception.

Manufacturing 104

Manufacturing Pharma Companies Drugs Pharmacy 104

Camargo

OCTOBER 14, 2020

ANDA applications rely on an approved product, provided in the FDA’s Orange Book as the Reference Listed Drug (RLD). Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. Camargo has worked with several companies on pump delivery systems and is at the forefront of digital therapy innovation.

Development 196

Development Insulin Drug Delivery Production 196

Roots Analysis

SEPTEMBER 13, 2023

It is worth mentioning that the first radiopharmaceutical peptide-drug conjugate Luthathera was approved by United States Food and Drug Administration (USFDA) in 2018 for the treatment of gastroenteropancreatic neuroendocrine tumors. It consists of somatostatin-derived peptide and DOTA complexed with radioactive isotope 77 Lu.

Development 40

Development Antibody Protein Drug Delivery Systems 40

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Combination products might be part drug, part device, or part software or hardware. By John W.M.

Regulation 59

Regulation Production Drug Delivery Insulin 59

The Pharma Data

JANUARY 27, 2021

FDA Investigational New Drug (“IND”)-enabling pharmacology studies. About Eurofins Discovery: Eurofins Discovery, a business operating under the Eurofins BioPharma Services division, has supported drug discovery research for over 40 years. About BetterLife Pharma: BetterLife Pharma Inc. For more information, please visit: [link].

In-Vitro 52

In-Vitro Containment Drugs Production 52

pharmaphorum

JANUARY 12, 2021

They also offer the potential for self-administration at home rather than in a health setting, making compliance with booster dosage potentially higher.”. “Non-injectables remove the need for health professional-led immunisation programmes, making widespread vaccine roll-outs quicker and easier and more affordable,” Channon told pharmaphorum.

Licensing 117

Licensing Licensing Vaccination Vaccine 117

XTalks

AUGUST 30, 2022

The pharmaceutical industry deals with threats such as product liability, cyberthreats, supply chain disruptions, competition from generic drugs and more. Public health and regulatory compliance entities depend on bureaucratic leadership to run effectively. Therefore, strategic intent is vital when making decisions.

Life Science 105

Life Science Generic Drugs Drug Delivery Compliance 105